Conditioning effects of narcotics in humans. 1978

C P O'Brien, and T Testa, and J Ternes, and R Greenstein

UI MeSH Term Description Entries
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D003213 Conditioning, Psychological Simple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response. Conditioning, Psychology,Psychological Conditioning,Social Learning Theory,Social Learning Theories,Theory, Social Learning
D003496 Cyclazocine An analgesic with mixed narcotic agonist-antagonist properties.
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

C P O'Brien, and T Testa, and J Ternes, and R Greenstein
January 1999, Psychosomatic medicine,
C P O'Brien, and T Testa, and J Ternes, and R Greenstein
January 1991, Psychopharmacology,
C P O'Brien, and T Testa, and J Ternes, and R Greenstein
February 2018, Addictive behaviors,
C P O'Brien, and T Testa, and J Ternes, and R Greenstein
July 1987, Psychophysiology,
C P O'Brien, and T Testa, and J Ternes, and R Greenstein
June 1974, Connecticut medicine,
C P O'Brien, and T Testa, and J Ternes, and R Greenstein
January 1981, Cleveland Clinic quarterly,
C P O'Brien, and T Testa, and J Ternes, and R Greenstein
January 1986, Neurotoxicology,
C P O'Brien, and T Testa, and J Ternes, and R Greenstein
January 2021, Frontiers in behavioral neuroscience,
C P O'Brien, and T Testa, and J Ternes, and R Greenstein
January 2000, Annals of the New York Academy of Sciences,
C P O'Brien, and T Testa, and J Ternes, and R Greenstein
October 1983, Anesthesiology,
Copied contents to your clipboard!